H

Humedix Co Ltd
KOSDAQ:200670

Watchlist Manager
Humedix Co Ltd
KOSDAQ:200670
Watchlist
Price: 45 250 KRW 7.74% Market Closed
Market Cap: 466.5B KRW
Have any thoughts about
Humedix Co Ltd?
Write Note
Humedix Co Ltd
/
Income Statement
/
Net Income (Common)

Humedix Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Humedix Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
H
Humedix Co Ltd
KOSDAQ:200670
Net Income (Common)
₩31.2B
CAGR 3-Years
40%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Net Income (Common)
₩165.3B
CAGR 3-Years
12%
CAGR 5-Years
31%
CAGR 10-Years
6%
SK Biopharmaceuticals Co Ltd
KRX:326030
Net Income (Common)
-₩32.9B
CAGR 3-Years
49%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Net Income (Common)
₩160.7B
CAGR 3-Years
28%
CAGR 5-Years
40%
CAGR 10-Years
17%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Net Income (Common)
₩5.1B
CAGR 3-Years
N/A
CAGR 5-Years
-15%
CAGR 10-Years
-6%
C
Celltrion Pharm Inc
KOSDAQ:068760
Net Income (Common)
₩16.5B
CAGR 3-Years
-26%
CAGR 5-Years
81%
CAGR 10-Years
16%
No Stocks Found

Humedix Co Ltd
Glance View

Market Cap
470.4B KRW
Industry
Pharmaceuticals

Humedix Co., Ltd. engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2014-12-26. The firm distributes its products within domestic market and to overseas markets

Intrinsic Value
63 381.73 KRW
Undervaluation 29%
Intrinsic Value
Price
H
What is Intrinsic Value?

See Also

What is Humedix Co Ltd's Net Income (Common)?
Net Income (Common)
31.2B KRW

Based on the financial report for Sep 30, 2024, Humedix Co Ltd's Net Income (Common) amounts to 31.2B KRW.

What is Humedix Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
28%

Over the last year, the Net Income (Common) growth was 31%. The average annual Net Income (Common) growth rates for Humedix Co Ltd have been 40% over the past three years , 28% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.